Advertisement

Topics

Search Results for "Mirrx Therapeutics"

08:27 EDT 28th May 2017 | BioPortfolio

Matching Channels

Tuberculosis Vaccines and Therapeutics

The WHO estimates that the largest number of new tuberculosis (TB) cases in 2008 occurred in the South-East Asia Region, which accounted for 34% of incident cases globally. However, the estimated inci...

KIACTA

KIACTA™ (also known as eprodisate) is an orally bioavailable small molecule intended for the treatment of AA amyloidosis, an orphan indication that results from long-standing inflammatory cond...

Anthrax Vaccines and Therapeutics

Anthrax is a zoonotic disease caused by the spore-forming bacterium Bacillus anthracis. The disease most commonly occurs in mammals (e.g., cattle, sheep, goats, camels, antelope. Anthrax occurs in hu...

AUT00063

AUT00063 develpoed by Autifony Therapeutics, is a novel, orally active small molecule designed to selectively modulate Kv3 potassium channels, which are important in central auditory processing. Pre...

Facebook - BioPortfolio Pages

BioPortfolio has launched a number of Facebook pages to allow our visitors to keep track with latest news, published paper and clinical trials by lead biotechnology and healthcare topics:- &nbs...

Matching News

Research Reports Initiation on Biotech Stocks -- Regulus Therapeutics, Abeona Therapeutics, ...

Regulus Therapeutics  San Diego, Californiaheadquartered Regulus Therapeutics Inc.'s stock finished Thursday's session 2.08% lower at $2.35with a total trading volume of 187,480 Read more...

CRISPR Therapeutics, Casebia Therapeutics partner with StrideBio

CRISPR Therapeutics, a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, and Casebia Therapeutics, a joint-venture established by CRISPR Therapeut...

M&As this week: Bioverativ Therapeutics, Horizon Pharma

Bioverativ Therapeutics has reached an agreement to acquire clinical-stage biotechnology company True North Therapeutics.

Deals this week: Spero Therapeutics, BioCryst Pharmaceuticals, Breath Therapeutics Holding

Spero Therapeutics has announced it has raised $51.7m in a series C financing round led by GV (formerly Google Ventures).

Deals this week: Akcea Therapeutics, Atara Biotherapeutics, Numab Therapeutics

Akcea Therapeutics plans to raise up to $100m through an initial public offering of its common stock shares.

Therapeutics Firms to Collaborate on Inhaled Drug Delivery for Hypertension

NewsRespira Therapeutics announces collaboration with United Therapeutics to treat pulmonary hypertension. The agreement involves the development and exclusive license of Respira's inhaled drug-device...

Arcturus Therapeutics to Present at the 19th Annual BIO CEO Investor Conference

About Arcturus Therapeutics, Inc. Founded in 2013 and based in San Diego, Arcturus Therapeutics, Inc. is an RNA medicines company with enabling technologies Read more...

Applied BioMath, LLC and CytomX Therapeutics, Inc. ...

Michael Kavanaugh, MD, Chief Scientific Officer of CytomX Therapeutics CytomX Therapeutics' novel Probody Platform allows the design of drugs that take advantage of unique Read more...

Matching PubMed Articles

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement